Rational Design of a Gd(III)–Cu(II) Nanobooster for Chemodynamic Therapy Against Cancer Cells

por Shi, Xin-Ya, Shen, Ting-Xiao, Zhang, Ao-Lin, Tan, Li-Tao, Shen, Wen-Chang, Zhong, Hai-Jiang, Zhang, Shun-Lin, Gu, Yu-Lan, Shen, Lei
Publicado 2022

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

por Shi, Xin-Ya, Shen, Ting-Xiao, Zhang, Ao-Lin, Tan, Li-Tao, Shen, Wen-Chang, Zhong, Hai-Jiang, Zhang, Shun-Lin, Gu, Yu-Lan, Shen, Lei
Publicado 2022

Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial

por Liu, Quan, Xu, Juan-Ying, Xu, Ye-Hong, Chen, Meng, Deng, Li-Chun, Wu, Jian-Ping, Zhou, Tong, Zhang, Li-Qin, Tan, Jie, Pu, Xing-Xiang, Shang, Yu-Long, Hua, Jun, Li, Yuan-Qin, Cai, Wei, Gu, Yu-Lan, Peng, Xing-Chen, Chan, Po-Chung, Jabbour, Salma K., Nam, Hae-Seong, Hua, Dong
Publicado 2022